Literature DB >> 2473278

C-erbB-2 gene product, a membrane protein commonly expressed on human fetal epithelial cells.

S Mori1, T Akiyama, Y Yamada, Y Morishita, I Sugawara, K Toyoshima, T Yamamoto.   

Abstract

C-erbB-2 is a human proto-oncogene which has homologies with the well known proto-oncogene c-erbB. The c-erbB-2 gene is amplified and overexpressed in some human adenocarcinomas. Its expression, in terms of RNA levels in normal human fetal kidney, lung and liver, has also been reported. In the present study, various fetal tissues from three human abortuses obtained at 9, 14 and 24 weeks of gestation, were studied immunohistologically by the ABC method and immunochemically by Western blot analysis for the distribution of c-erbB-2 gene product at the protein level. A polyclonal antibody raised in rabbit by immunization with a synthetic polypeptide corresponding to part of the predicted intracytoplasmic domain was used. Strong immunoreactivity was observed on the membrane of most of the epithelial cells examined, including transitional cells of the renal pelvis and ureter, glandular cells of the gastrointestinal tract, renal tubuli, bronchi and pancreas, and stratified epithelium of the oral cavity, trachea and esophagus in this gestational period. A much more intense reaction was observed on the basolateral sides than on the apical side of these cells. No immunoreactivity was found in the liver, adrenal gland, striated and smooth muscles, brain, endothelium or fibroblasts. Western blot analysis confirmed increased expression of the c-erbB-2 gene product in fetal kidney and intestine but not in the brain. As the protein seems to be poorly expressed in normal adult epithelial cells except for renal tubuli, the present results suggest that the protein is a membrane-associated receptor protein which controls some specific reaction of fetal epithelium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473278

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  22 in total

1.  Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: oligomerization of kinase domains.

Authors:  R Murali; P J Brennan; T Kieber-Emmons; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas.

Authors:  B S Chozick; D L Benzil; E G Stopa; J C Pezzullo; N W Knuckey; M H Epstein; S D Finkelstein; P W Finch
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

3.  Amplification and overexpression of the c-erbB-2 protooncogene in human gastric cancer.

Authors:  K Sasaki; Y Tomita; M Azuma; S Shida; B Simizu
Journal:  Gastroenterol Jpn       Date:  1992-04

4.  Structural and functional aspects of the multiplicity of Neu differentiation factors.

Authors:  D Wen; S V Suggs; D Karunagaran; N Liu; R L Cupples; Y Luo; A M Janssen; N Ben-Baruch; D B Trollinger; V L Jacobsen
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

5.  Kid, a novel kinesin-like DNA binding protein, is localized to chromosomes and the mitotic spindle.

Authors:  N Tokai; A Fujimoto-Nishiyama; Y Toyoshima; S Yonemura; S Tsukita; J Inoue; T Yamamota
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

6.  Analysis of protooncogene c-erbB-2 in benign and malignant human prostate.

Authors:  M Watanabe; T Nakada; H Yuta
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 7.  The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology.

Authors:  Fenghua Zeng; Amar B Singh; Raymond C Harris
Journal:  Exp Cell Res       Date:  2008-08-19       Impact factor: 3.905

8.  Effectiveness of an adriamycin immunoconjugate that recognizes the C-erbB-2 product on breast cancer cell lines.

Authors:  H Jinno; M Ueda; K Enomoto; T Ikeda; P Kyriakos; M Kitajima
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

9.  Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.

Authors:  X Qian; C M LeVea; J K Freeman; W C Dougall; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

10.  Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the placenta.

Authors:  D P Wang; S Fujii; I Konishi; Y Nanbu; T Iwai; H Nonogaki; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.